Follow
Roberto Visentin
Roberto Visentin
Assistant Professor, Department of Information Engineering, University of Padova
Verified email at dei.unipd.it
Title
Cited by
Cited by
Year
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial
J Kropff, S Del Favero, J Place, C Toffanin, R Visentin, M Monaro, ...
The lancet Diabetes & endocrinology 3 (12), 939-947, 2015
2162015
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas
BP Kovatchev, E Renard, C Cobelli, HC Zisser, P Keith-Hynes, ...
Diabetes care 36 (7), 1851-1858, 2013
1922013
The UVA/Padova type 1 diabetes simulator goes from single meal to single day
R Visentin, E Campos-Náñez, M Schiavon, D Lv, M Vettoretti, M Breton, ...
Journal of diabetes science and technology 12 (2), 273-281, 2018
1232018
First use of model predictive control in outpatient wearable artificial pancreas
S Del Favero, D Bruttomesso, F Di Palma, G Lanzola, R Visentin, A Filippi, ...
Diabetes care 37 (5), 1212-1215, 2014
1012014
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: results of a single-arm 1-month experience compared with a previously …
E Renard, A Farret, J Kropff, D Bruttomesso, M Messori, J Place, ...
Diabetes Care 39 (7), 1151-1160, 2016
992016
Randomized summer camp crossover trial in 5-to 9-year-old children: outpatient wearable artificial pancreas is feasible and safe
S Del Favero, F Boscari, M Messori, I Rabbone, R Bonfanti, A Sabbion, ...
Diabetes Care 39 (7), 1180-1185, 2016
842016
Circadian variability of insulin sensitivity: physiological input for in silico artificial pancreas
R Visentin, C Dalla Man, YC Kudva, A Basu, C Cobelli
Diabetes technology & therapeutics 17 (1), 1-7, 2015
842015
Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive …
S Del Favero, J Place, J Kropff, M Messori, P Keith‐Hynes, R Visentin, ...
Diabetes, Obesity and Metabolism 17 (5), 468-476, 2015
832015
Toward a run-to-run adaptive artificial pancreas: In silico results
C Toffanin, R Visentin, M Messori, F Di Palma, L Magni, C Cobelli
IEEE Transactions on Biomedical Engineering 65 (3), 479-488, 2017
792017
The university of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trial
R Visentin, C Dalla Man, B Kovatchev, C Cobelli
Diabetes technology & therapeutics 16 (7), 428-434, 2014
792014
Multinight “bedside” closed-loop control for patients with type 1 diabetes
SA Brown, BP Kovatchev, MD Breton, SM Anderson, P Keith-Hynes, ...
Diabetes technology & therapeutics 17 (3), 203-209, 2015
612015
One-day Bayesian cloning of type 1 diabetes subjects: toward a single-day UVA/Padova type 1 diabetes simulator
R Visentin, C Dalla Man, C Cobelli
IEEE Transactions on Biomedical Engineering 63 (11), 2416-2424, 2016
602016
Randomized controlled trial of a MUFA or fiber-rich diet on hepatic fat in prediabetes
I Errazuriz, S Dube, M Slama, R Visentin, S Nayar, H O’Connor, C Cobelli, ...
The Journal of Clinical Endocrinology & Metabolism 102 (5), 1765-1774, 2017
572017
Personalized blood glucose prediction: A hybrid approach using grammatical evolution and physiological models
I Contreras, S Oviedo, M Vettoretti, R Visentin, J Vehí
PloS one 12 (11), e0187754, 2017
562017
Individually adaptive artificial pancreas in subjects with type 1 diabetes: a one-month proof-of-concept trial in free-living conditions
M Messori, J Kropff, S Del Favero, J Place, R Visentin, R Calore, ...
Diabetes Technology & Therapeutics 19 (10), 560-571, 2017
452017
Evaluating the experience of children with type 1 diabetes and their parents taking part in an artificial pancreas clinical trial over multiple days in a diabetes camp setting
A Troncone, R Bonfanti, D Iafusco, I Rabbone, A Sabbion, R Schiaffini, ...
Diabetes Care 39 (12), 2158-2164, 2016
302016
Improving efficacy of inhaled technosphere insulin (Afrezza) by postmeal dosing: in-silico clinical trial with the University of Virginia/Padova type 1 diabetes simulator
R Visentin, C Giegerich, R Jäger, R Dahmen, A Boss, M Grant, ...
Diabetes technology & therapeutics 18 (9), 574-585, 2016
302016
Accuracy of a CGM sensor in pediatric subjects with type 1 diabetes. Comparison of three insertion sites: arm, abdomen, and gluteus
S Faccioli, S Del Favero, R Visentin, R Bonfanti, D Iafusco, I Rabbone, ...
Journal of diabetes science and technology 11 (6), 1147-1154, 2017
272017
Dual glucagon‐like peptide‐1 receptor/glucagon receptor agonist SAR425899 improves beta‐cell function in type 2 diabetes
R Visentin, M Schiavon, B Göbel, M Riz, C Cobelli, T Klabunde, ...
Diabetes, Obesity and Metabolism 22 (4), 640-647, 2020
212020
Overnight closed-loop control improves glycemic control in a multicenter study of adults with type 1 diabetes
SA Brown, MD Breton, SM Anderson, L Kollar, P Keith-Hynes, CJ Levy, ...
The Journal of Clinical Endocrinology & Metabolism 102 (10), 3674-3682, 2017
212017
The system can't perform the operation now. Try again later.
Articles 1–20